NCT03379922

Brief Summary

Extracorporeal shockwave lithotripsy is an outpatient treatment for patients with intrarenal calculi. Standard of care involves offering oral analgesia prior to commencing the treatment. Most patients do not take the offered analgesia after the initial treatment. It has been suggested that distraction techniques may be equivalent to oral analgesia in improving tolerability of extracorporeal shockwave lithotripsy treatment. The use of distraction techniques also removes the potential side effects of mediation administration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2017

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 20, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2018

Completed
Last Updated

April 17, 2019

Status Verified

April 1, 2019

Enrollment Period

1.7 years

First QC Date

December 12, 2017

Last Update Submit

April 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain score

    Patients will complete the short form McGill pain questionnaire, subdivided into 11 sensory descriptors, 4 affective descriptors and a visual analogue score. Sensory and affective descriptors are each rated as 0-3. Sensory minimum score 0/33 (no pain), maximum score 33/33 (maximum pain). Affective minimum score 0/12 (no pain), maximum score 12/12 (maximum pain). Visual analogue score 0 to 10 (0 being no pain and 10 being worst possible pain).

    At the time of completing lithotripsy treatment (3000 shocks over 40 to 60 minutes)

Secondary Outcomes (1)

  • Early cessation of lithotripsy treatment

    At the time of completing lithotripsy treatment (3000 shocks over 40 to 60 minutes)

Study Arms (3)

Stress balls

EXPERIMENTAL

The first arm will be given stress balls to squeeze during their treatment and will also receive standard care (the offer of oral analgesia)

Behavioral: Stress balls

Headphones

EXPERIMENTAL

The second arm will be given headphones to listen to music during their treatment and will also receive standard care.

Behavioral: Headphones

Control

NO INTERVENTION

The control group will receive standard care (the offer of oral analgesia)

Interventions

Stress ballsBEHAVIORAL

Squeezing stress balls while receiving ESWL treatment

Stress balls
HeadphonesBEHAVIORAL

Listening to music while receiving ESWL treatment

Headphones

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years old
  • First ESWL treatment

You may not qualify if:

  • Patients not capable of giving informed consent
  • Patients unsuitable for ESWL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College Hospital Galway

Galway, Galway, Ireland

Location

Related Publications (1)

  • Browne C, Redmond E, Kelly T, Rogers E, O'Malley P, Nusrat N, Jaffry S, Durkan G, Walsh K, Dowling C, D'Arcy FT. Strategies to maximise patient comfort during extracorporeal shockwave lithotripsy - A randomised controlled trial. Surgeon. 2021 Aug;19(4):207-211. doi: 10.1016/j.surge.2020.07.002. Epub 2020 Aug 6.

MeSH Terms

Conditions

Nephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Study Officials

  • Cliodhna Browne, MRCSI

    University College Hospital Galway, Ireland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Specialist Registrar

Study Record Dates

First Submitted

December 12, 2017

First Posted

December 20, 2017

Study Start

March 27, 2017

Primary Completion

December 12, 2018

Study Completion

December 12, 2018

Last Updated

April 17, 2019

Record last verified: 2019-04

Locations